UK markets closed

Teva Pharmaceutical Industries Limited (0LER.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
14.00+0.07 (+0.54%)
At close: 05:31PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 15.70B
Enterprise value 32.63B
Trailing P/E N/A
Forward P/E 5.85
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.98
Price/book (mrq)2.10
Enterprise value/revenue 2.06
Enterprise value/EBITDA 20.94

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 357.88%
S&P500 52-week change 323.57%
52-week high 314.48
52-week low 37.10
50-day moving average 313.56
200-day moving average 310.94

Share statistics

Avg vol (3-month) 382.05k
Avg vol (10-day) 314.26k
Shares outstanding 51.12B
Implied shares outstanding 61.38B
Float 81.12B
% held by insiders 10.00%
% held by institutions 149.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin -14.88%
Operating margin (ttm)16.52%

Management effectiveness

Return on assets (ttm)3.48%
Return on equity (ttm)-26.58%

Income statement

Revenue (ttm)15.02B
Revenue per share (ttm)13.47
Quarterly revenue growth (yoy)2.40%
Gross profit (ttm)6.97B
EBITDA 3.71B
Net income avi to common (ttm)-2.23B
Diluted EPS (ttm)-1.90
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.67B
Total cash per share (mrq)2.38
Total debt (mrq)21.02B
Total debt/equity (mrq)272.65%
Current ratio (mrq)1.02
Book value per share (mrq)6.29

Cash flow statement

Operating cash flow (ttm)1.7B
Levered free cash flow (ttm)3.08B